Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia.

Song CH, Fan X, Exeter CJ, Hess EJ, Jinnah HA.

Neurobiol Dis. 2012 Oct;48(1):66-78. doi: 10.1016/j.nbd.2012.05.009.

Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.

Atassi MZ, Jankovic J, Steward LE, Aoki KR, Dolimbek BZ.

Immunobiology. 2012 Jan;217(1):17-27. doi: 10.1016/j.imbio.2011.08.009.

Dystonia as a presenting feature of alcohol withdrawal.

Bijjal S, Subodh BN, Narayanaswamy JC, Chand P, Benegal V, Murthy P.

J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):E15-6. doi: 10.1176/appi.neuropsych.11010026. No abstract available.

Broad spectrum of dystonia associated with a novel thanatosis-associated protein domain-containing apoptosis-associated protein 1 mutation in a Japanese family with dystonia 6, torsion.

Miyamoto R, Ohta E, Kawarai T, Koizumi H, Sako W, Izumi Y, Obata F, Kaji R.

Mov Disord. 2012 Sep 1;27(10):1324-5. doi: 10.1002/mds.25106. No abstract available.

Steroid-responsive focal epilepsy with focal dystonia accompanied by glutamate receptor delta2 antibody.

Matsumoto H, Okabe S, Hirakawa-Yamada M, Takahashi Y, Satoh N, Igeta Y, Hashida H.

J Neuroimmunol. 2012 Aug 15;249(1-2):101-4. doi: 10.1016/j.jneuroim.2012.04.009.

Botulinum toxin physiology in focal hand and cranial dystonia.

Karp BI.

Toxins (Basel). 2012 Nov 20;4(11):1404-14. doi: 10.3390/toxins4111404. Review.

Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations.

Paisán-Ruiz C, Li A, Schneider SA, Holton JL, Johnson R, Kidd D, Chataway J, Bhatia KP, Lees AJ, Hardy J, Revesz T, Houlden H.

Neurobiol Aging. 2012 Apr;33(4):814-23. doi: 10.1016/j.neurobiolaging.2010.05.009.

Aripiprazole-induced oculogyric crisis (acute dystonia).

Bhachech JT.

J Pharmacol Pharmacother. 2012 Jul;3(3):279-81. doi: 10.4103/0976-500X.99446.

Treatment of focal dystonia.

Batla A, Stamelou M, Bhatia KP.

Curr Treat Options Neurol. 2012 Jun;14(3):213-29. doi: 10.1007/s11940-012-0169-6.

Phenotypic overlap in familial and sporadic primary adult-onset extracranial dystonia.

Defazio G, Abbruzzese G, Girlanda P, Liguori R, Santoro L, Tinazzi M, Berardelli A.

J Neurol. 2012 Nov;259(11):2414-8. doi: 10.1007/s00415-012-6514-6.

Multichannel Electromyographic Mapping to Optimize OnabotulinumtoxinA Efficacy in Cervical Dystonia.

Kilbane C, Ostrem J, Galifianakis N, Grace J, Markun L, Glass GA.

Tremor Other Hyperkinet Mov (N Y). 2012;2. pii: tre-02-91-598-1. doi: 10.7916/D8XK8D8V.

Elimination of dysphagia using ultrasound guidance for botulinum toxin injections in cervical dystonia.

Hong JS, Sathe GG, Niyonkuru C, Munin MC.

Muscle Nerve. 2012 Oct;46(4):535-9. doi: 10.1002/mus.23409.

Occurrence of GCH1 gene mutations in a group of Indian dystonia patients.

Naiya T, Misra AK, Biswas A, Das SK, Ray K, Ray J.

J Neural Transm (Vienna). 2012 Nov;119(11):1343-50. doi: 10.1007/s00702-012-0777-z.

Reorganization of the human somatosensory cortex in hand dystonia.

Catalan MJ, Ishii K, Bara-Jimenez W, Hallett M.

J Mov Disord. 2012 May;5(1):5-8. doi: 10.14802/jmd.12002.

Mutational screening of THAP1 in a German population with primary dystonia.

Kaffe M, Gross N, Castrop F, Dresel C, Gieger C, Lichtner P, Haslinger B, Winkelmann J.

Parkinsonism Relat Disord. 2012 Jan;18(1):104-6. doi: 10.1016/j.parkreldis.2011.06.023. No abstract available.